Related Experiment Video
Updated: Sep 6, 2025
09:20
An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function
Published on: May 4, 2021
3.8K
Insight Into Rho Kinase Isoforms in Obesity and Energy Homeostasis.
1Herman B Wells Center for Pediatric Research, Department of Pediatrics, Indiana University, School of Medicine, Indianapolis, IN, United States.
Frontiers in Endocrinology
|June 30, 2022
Summary
Rho kinase (ROCK) signaling is implicated in obesity and insulin resistance. Understanding ROCK1 and ROCK2 roles in adipogenesis and metabolism is crucial for developing new obesity treatments.
Area of Science:
- Metabolic disorders
- Obesity research
- Cell signaling
Background:
- Obesity and type 2 diabetes are growing global health concerns.
- Rho kinase (ROCK) signaling is increasingly recognized in metabolic syndrome.
- ROCK1 and ROCK2 are key regulators of cellular processes relevant to metabolism.
Purpose of the Study:
- To review the role of ROCK signaling in obesity and insulin resistance.
- To highlight the specific functions of ROCK1 and ROCK2 isoforms in adipogenesis and energy homeostasis.
- To emphasize the therapeutic potential of isoform-selective ROCK inhibitors.
Main Methods:
- Review of existing literature on ROCK signaling in metabolic disorders.
- Analysis of studies using ROCK pan-inhibitors and isoform-specific genetic models.
- Focus on white and beige adipogenesis, insulin sensitivity, and energy balance regulation.
Main Results:
- ROCK activity is linked to obesity, insulin resistance, dyslipidemia, and hypertension.
- ROCK signaling influences actin dynamics crucial for white and beige adipogenesis.
- Studies in animal models show beneficial effects of ROCK inhibition on obesity and diabetes complications.
Conclusions:
- ROCK isoforms play distinct roles in metabolic regulation.
- Further research into ROCK2 is warranted due to recent inhibitor development.
- Targeting ROCK isoforms offers a promising strategy for treating obesity and related metabolic diseases.
More Related Videos
09:41Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
3.0K
08:34Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
15.2K
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
01:25cAMP-dependent Protein Kinase Pathways
6.6K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.6K
01:07MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
01:20The JAK-STAT Signaling Pathway
9.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.2K
01:22Amplifying Signals via Enzymatic Cascade
8.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.7K
01:28Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K